should make field experiments a priority and should consider providing start-up aid to private companies that are willing to institute programs experimentally and subject them to independent evaluation.


Glantz, M.D. 1992 A developmental psychopathology model of drug abuse vulnerability. Pp. 389-418 in M. Glantz and R. Pickens, eds., Vulnerability of Drug Abuse. Washington, D.C.: American Psychological Association.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement